These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31805971)

  • 1. Smoking heroin with cannabis versus injecting heroin: unexpected impact on treatment outcomes.
    Morgan N; Daniels W; Subramaney U
    Harm Reduct J; 2019 Dec; 16(1):65. PubMed ID: 31805971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective observational study of heroin users in Johannesburg, South Africa: Assessing psychiatric comorbidities and treatment outcomes.
    Morgan N; Daniels W; Subramaney U
    Compr Psychiatry; 2019 Nov; 95():152137. PubMed ID: 31669789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twelve-month outcomes for heroin dependence treatments: does route of administration matter?
    Darke S; Ross J; Teesson M
    Drug Alcohol Rev; 2005 Mar; 24(2):165-71. PubMed ID: 16076586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and treatment outcomes of women with heroin dependence in Johannesburg, South Africa.
    Morgan N; Daniels W; Subramaney U
    S Afr Med J; 2020 May; 110(6):540-545. PubMed ID: 32880569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of an 18-month, NHS-based, treatment exposure for heroin dependence: results from the London Area Treat 2000 Study.
    Schifano F; Martinotti G; Cunniff A; Reissner V; Scherbaum N; Ghodse H
    Am J Addict; 2012; 21(3):268-73. PubMed ID: 22494230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).
    Metrebian N; Groshkova T; Hellier J; Charles V; Martin A; Forzisi L; Lintzeris N; Zador D; Williams H; Carnwath T; Mayet S; Strang J
    Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in route of drug administration among continuing heroin users: outcomes 1 year after intake to treatment.
    Gossop M; Stewart D; Marsden J; Kidd T; Strang J
    Addict Behav; 2004 Aug; 29(6):1085-94. PubMed ID: 15236809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heroin transition risk among daily and non-daily cannabis users who are non-injectors of heroin.
    Valdez A; Cepeda A; Neaigus A; Russell A
    Int J Drug Policy; 2008 Dec; 19(6):442-9. PubMed ID: 19038723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk perception, changing social context, and norms prevent transition to regular injection among people who smoke heroin.
    Harris J; Shorter GW; Davidson G; Best P
    Drug Alcohol Depend; 2020 Mar; 208():107878. PubMed ID: 32014646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Every 'never' I ever said came true": transitions from opioid pills to heroin injecting.
    Mars SG; Bourgois P; Karandinos G; Montero F; Ciccarone D
    Int J Drug Policy; 2014 Mar; 25(2):257-66. PubMed ID: 24238956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heroin users' careers and perceptions of drug use: a comparison of smokers and injectors in the Mersey region.
    Cousins P; Bentall RP
    Br J Addict; 1989 Dec; 84(12):1467-72. PubMed ID: 2611429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: associated health gains and harm reductions.
    Metrebian N; Shanahan W; Wells B; Stimson GV
    Med J Aust; 1998 Jun; 168(12):596-600. PubMed ID: 9673620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.
    Ayres R; Ingram J; Rees A; Neale J; Beattie A; Telfer M
    Subst Abuse Treat Prev Policy; 2014 Nov; 9():44. PubMed ID: 25407020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severity of heroin dependence and HIV risk. II. Sharing injecting equipment.
    Gossop M; Griffiths P; Powis B; Strang J
    AIDS Care; 1993; 5(2):159-68. PubMed ID: 8392383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heroin snorters versus injectors: comparison on drug use and treatment outcome in age-matched samples.
    Carpenter MJ; Chutuape MA; Stitzer ML
    Drug Alcohol Depend; 1998 Dec; 53(1):11-5. PubMed ID: 10933336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants.
    McKetin R; Ross J; Kelly E; Baker A; Lee N; Lubman DI; Mattick R
    Drug Alcohol Rev; 2008 May; 27(3):277-85. PubMed ID: 18368609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Criminal outcomes and costs of treatment services for injecting and non-injecting heroin users: evidence from a national prospective cohort survey.
    Healey A; Knapp M; Marsden J; Gossop M; Stewart D
    J Health Serv Res Policy; 2003 Jul; 8(3):134-41. PubMed ID: 12869338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of major depression and drug-related problems amongst heroin users across 36 months.
    Darke S; Mills K; Teesson M; Ross J; Williamson A; Havard A
    Psychiatry Res; 2009 Mar; 166(1):7-14. PubMed ID: 19215987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High rates of transitions to injecting drug use among Mexican American non-injecting heroin users in San Antonio, Texas (never and former injectors).
    Valdez A; Neaigus A; Kaplan C; Cepeda A
    Drug Alcohol Depend; 2011 Apr; 114(2-3):233-6. PubMed ID: 21075561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A qualitative analysis of transitions to heroin injection in Kenya: implications for HIV prevention and harm reduction.
    Guise A; Dimova M; Ndimbii J; Clark P; Rhodes T
    Harm Reduct J; 2015 Sep; 12():27. PubMed ID: 26337729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.